Pazolimus: pazopanib plus sirolimus following progression on pazopanib, a retrospective case series analysis.
about
Targeted therapy for soft tissue sarcomas in adolescents and young adults.Clinical benefit of antiangiogenic therapy in advanced and metastatic chondrosarcomaPhase Ib/II Study of the Safety and Efficacy of Combination Therapy with Multikinase VEGF Inhibitor Pazopanib and MEK Inhibitor Trametinib In Advanced Soft Tissue Sarcoma.
P2860
Pazolimus: pazopanib plus sirolimus following progression on pazopanib, a retrospective case series analysis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Pazolimus: pazopanib plus siro ...... spective case series analysis.
@ast
Pazolimus: pazopanib plus siro ...... spective case series analysis.
@en
type
label
Pazolimus: pazopanib plus siro ...... spective case series analysis.
@ast
Pazolimus: pazopanib plus siro ...... spective case series analysis.
@en
prefLabel
Pazolimus: pazopanib plus siro ...... spective case series analysis.
@ast
Pazolimus: pazopanib plus siro ...... spective case series analysis.
@en
P2093
P2860
P1433
P1476
Pazolimus: pazopanib plus siro ...... spective case series analysis.
@en
P2093
P2860
P2888
P356
10.1186/S12885-016-2618-1
P407
P50
P577
2016-08-08T00:00:00Z
P6179
1013246309